Member Info for Soupdragon78

goup, if we haven't had figures on the Ox deal, how can you say it will 'generate to 6p level'?

Will be interesting to see what happens once the volume drops. We’ve seen over 125m shares traded over the last two weeks and the sp is lower than it was back then.

two pennies worth on that one.

Firstly I don't think AC has anything to do with Ebers, he's never been identified on anything relating to them.
Secondly, I don't think they would transfer, more likely DT would have to sell to fund his stake in Ebers, under the Canadian qualifying transaction system they are going through at the moment, the directors have to stump up a good chunk through their own cash.

Ganner, yes. Based solely on NXP002, before clinical trials. See their note dated 10 March

https://www.proactiveinvestors.co.uk/companies/news/947277/nuformix-eyes-big-opportunity-with-new-forms-of-fibrosis-and-cancer-drugs-947277.html

Dunno whats going on, but its certainly more interesting than the low volume days.

FX, since the 7th April theres been about 23% of shares in issue traded with no TR1.

Why do people never say 'for every buyer there is a seller' when the price is going up?

Agreed filter, its a ridiculous system, especially nowadays its really easy for the tech to instantly calculate and notify without the individual having to do anything.

Minx that’s true, there was a 9.6m after the bell plus another 1.6m

20m+ sells after the bell.

Indeed FX, we are all excited despite the sp not even getting back to where it was at the start of the year.

Fingers crossed there is something substantial to back this up

Well, at least there’s something going on, more interesting than the low volume days.

Somebody seems interested at this price. Two lots of 1m buys just gone through

Thats ok flap, I didn't see it as an attack.

Flap, re. My comment about someone gathering stock.

I do get things wrong sometimes.

Interesting price action the past couple of days.

Disappointed it’s down, but unusual as they will let you sell large quantities (up to 1m in open market), with few large buys going through.
Has the feel of stock being gathered.

aj, i think the company is in the process of producing what we all want, the problem is we all want it now despite the company telling us it won’t.

Thanks FX, will be disappointing if confirmed but such are these things. They may have been marked down for already having been given a grant previously for a similar purpose.

Really? So there is a perfect market which will see a company achieve a workflow target and value them at an exact amount according to that achievement?

Ok, so let’s do a quick comparison to see if a board has ultimate control of the share price.

NFX has a product that has been tested on human tissue, twice, and found to be an improvement on standard of care. The company is valued at around £13m Mcap.
C4X has a similar product, actually I should say a similar idea. They have yet to figure out which molecules to use, or patent it, they haven’t tested it or got a programme for testing it. The company is valued at £90m Mcap.

NFX management have achieved milestones in the product development whereas the others have yet to start.
Who has ‘ultimate control’ again?